Hydration in advanced cancer: Can bioelectrical impedance analysis improve the evidence base? A systematic review of the literature

Journal of Pain and Symptom Management

Volumn 46, Issue 3, 2013, Pages 433-446.e6

  Nwosu, Amara Callistus ^a   Mayland, Catriona R ^a,b   Mason, Stephen R ^a   Khodabukus, Andrew F ^a   Varro, Andrea ^a   Ellershaw, John E ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Bioelectrical Impedance Analysis; Cancer; Clinically Assisted Hydration; Dehydration; Hydration; Palliative Care

Indexed keywords

CREATININE; DIURETIC AGENT; OPIATE; UREA;

ADVANCED CANCER; ASCITES; BIOELECTRICAL IMPEDANCE ANALYSIS; BIOENERGY; BODY MASS; BREAST CANCER; CACHEXIA; CANCER PALLIATIVE THERAPY; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COLORECTAL CANCER; CREATININE BLOOD LEVEL; DEHYDRATION; ELECTRIC CURRENT; FATIGUE; HUMAN; HYDRATION; HYPOTENSION; IMPEDANCE; INTRACELLULAR SPACE; LUNG CANCER; ORTHOSTATIC HYPOTENSION; OSMOTIC PRESSURE; PANCREAS CANCER; PERIPHERAL EDEMA; PLASMA OSMOLALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYMPTOM ASSESSMENT; SYSTEMATIC REVIEW; TERMINALLY ILL PATIENT; UREA BLOOD LEVEL; URINE OSMOLALITY; VISUAL ANALOG SCALE; XEROSTOMIA;

BIOELECTRICAL IMPEDANCE ANALYSIS; CANCER; CLINICALLY ASSISTED HYDRATION; DEHYDRATION; HYDRATION; PALLIATIVE CARE;

CARDIOGRAPHY, IMPEDANCE; CAUSALITY; COMORBIDITY; DEHYDRATION; EVIDENCE-BASED MEDICINE; FLUID THERAPY; HUMANS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84888639100     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2012.08.018     Document Type: Review

References (92)

1. Viola RA, Wells GA, Peterson J. The effects of fluid status and fluid therapy on the dying: A systematic review. J Palliat Care 1997;13:41e52.
2. Cerchietti L, Navigante A, Sauri A, Palazzo F. Hypodermoclysis for control of dehydration in terminal-stage cancer. Int J Palliat Nurs 2000;6: 370e374.
3. Fine RL. Ethical issues in artificial nutrition and hydration. Nutr Clin Pract 2006;21:118e125.
4. Raijmakers NJ, van ZL, Costantini M, et al. Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol 2011;22: 1478e1486.
5. Parkash R, Burge F. The family?s perspective on issues of hydration in terminal care. J Palliat Care 1997;13:23e27.
6. Mercadante S, Ferrera P, Girelli D, Casuccio A. Patients? and relatives? perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage 2005;30:354e358.
7. Malia C, Bennett MI. What influences patients? decisions on artificial hydration at the end of life? A Q-methodology study. J Pain Symptom Manage 2011;42:192e201.
8. Good P, Cavenagh J, Mather M, Ravenscroft P. Medically assisted hydration for palliative care patients. Cochrane Database Syst Rev 2008;2: CD006273.
9. van der RP, Good P, Higgins I, Sneesby L. Palliative care professionals? perceptions of nutrition and hydration at the end of life. Int J Palliat Nurs 2008;14:145e151.
10. Ganzini L. Artificial nutrition and hydration at the end of life: Ethics and evidence. Palliat Support Care 2006;4:135e143.
11. Dalal S, Del FE, Bruera E. Is there a role for hydration at the end of life? Curr Opin Support Palliat Care 2009;3:72e78.
12. GeneralMedicalCouncil.Treatment care towards end life: Good practice decision making. 2010. Available from: http://www.gmc-uk.org/guidance/ethical- guidance/end-of-life-adult-patients-not-expected- to-die-imminently.asp. Accessed August 2, 2012.
13. Mange K, Matsuura D, Cizman B, et al. Language guiding therapy: The case of dehydration versus volume depletion. Ann Intern Med 1997;127: 848e853.
14. Sarhill N, Walsh D, Nelson K, Davis M. Evaluation and treatment of cancer-related fluid deficits: volume depletion and dehydration. Support Care Cancer 2001;9:408e419.
15. Davis MP, Yavuzsen T, Khoshknabi D, et al. Bioelectrical impedance phase angle changes during hydration and prognosis in advanced cancer. Am J Hosp Palliat Care 2009;26:180e187.
16. Steiner N, Bruera E. Methods of hydration in palliative care patients. J Palliat Care 1998;14:6e13.
17. Haussinger D, Lang F, Gerok W. Regulation of cell function by the cellular hydration state. Am J Physiol 1994;267:E343eE355.
18. Haussinger D, Gerok W. Role of the cellular hydration state for cellular function: Physiological and pathophysiological aspects. Adv Exp Med Biol 1994; 368:33e44.
19. Johnson BE, Chute JP, Rushin J, et al. A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 1997;156:1669e1678.
20. McDonald GA, Dubose TD Jr. Hyponatremia in the cancer patient. Oncology (Williston Park) 1993; 7:55e64.
21. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer 2007;15:1341e1347.
22. Sandifer MG. Hyponatremia due to psychotropic drugs. J Clin Psychiatry 1983;44:301e303.
23. Finfgeld DL. SSRI-related hyponatremia among aging adults. J Psychosoc Nurs Ment Health Serv 2003;41:12e16.
24. Vivanti A, Harvey K, Ash S, Battistutta D. Clinical assessment of dehydration in older people admitted to hospital: What are the strongest indicators? Arch Gerontol Geriatr 2008;47:340e355.
25. Gamble JL. Chemical anatomy, physiology and pathology of extracellular fluid. Cambridge, MA: Harvard Medical School, Department of Pediatrics, 1939.
26. Piccoli A. Bioelectric impedance measurement for fluid status assessment. Contrib Nephrol 2010; 164:143e152.
27. Barbosa-Silva MC, Barros AJ. Bioelectrical impedance analysis in clinical practice: A new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 2005;8:311e317.
28. Hawker S, Payne S, Kerr C, Hardey M, Powell J. Appraising the evidence: Reviewing disparate data systematically. Qual Health Res 2002;12:1284e1299.
29. Kavouras SA. Assessing hydration status. Curr Opin Clin Nutr Metab Care 2002;5:519e524.
30. Thomas DR, Cote TR, Lawhorne L, et al. Understanding clinical dehydration and its treatment. J Am Med Dir Assoc 2008;9:292e301.
31. Weinberg AD, Minaker KL. Dehydration. Evaluation and management in older adults. Council on Scientific Affairs, American Medical Association. JAMA 1995;274:1552e1556.
32. Thomas DR, Tariq SH, Makhdomm S, Haddad R, Moinuddin A. Physician misdiagnosis of dehydration in older adults. J Am Med Dir Assoc 2004;5(2 Suppl):S30eS34.
33. Gross CR, Lindquist RD, Woolley AC, et al. Clinical indicators of dehydration severity in elderly patients. J Emerg Med 1992;10:267e274.
34. Eaton D, Bannister P, Mulley GP, Connolly MJ. Axillary sweating in clinical assessment of dehydration in ill elderly patients. BMJ 1994;308:1271.
35. Morita T, Hyodo I, Yoshimi T, et al. Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol 2005;16:640e647.
36. Morita T, Hyodo I, Yoshimi T, et al. Artificial hydration therapy, laboratory findings, and fluid balance in terminally ill patients with abdominal malignancies. J Pain Symptom Manage 2006;31: 130e139.
37. Bruera E, Sala R, Rico MA, et al. Effects of parenteral hydration in terminally ill cancer patients: A preliminary study. J Clin Oncol 2005;23: 2366e2371.
38. McGee S, Abernethy WB III, Simel DL. The rational clinical examination. Is this patient hypovolemic? JAMA 1999;281:1022e1029.
39. Johnson DR, Douglas D, Hauswald M, Tandberg D. Dehydration and orthostatic vital signs in women with hyperemesis gravidarum. Acad Emerg Med 1995;2:692e697.
40. Koziol-McLain J, Lowenstein SR, Fuller B. Orthostatic vital signs in emergency department patients. Ann Emerg Med 1991;20:606e610.
41. Verhaeverbeke I, Mets T. Drug-induced orthostatic hypotension in the elderly: Avoiding its onset. Drug Saf 1997;17:105e118.
42. Simonds WF. The molecular basis of opioid receptor function. Endocr Rev 1988;9:200e212.
43. Sarhill N, Mahmoud F, Walsh D, et al. Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 2003;11:652e659.
44. Morita T, Tei Y, Inoue S, Suga A, Chihara S. Fluid status of terminally ill cancer patients with intestinal obstruction: An exploratory observational study. Support Care Cancer 2002;10:474e479.
45. Schriger DL, Baraff LJ. Capillary refilldis it a useful predictor of hypovolemic states? Ann Emerg Med 1991;20:601e605.
46. Gorelick MH, Shaw KN, Murphy KO. Validity and reliability of clinical signs in the diagnosis of dehydration in children. Pediatrics 1997;99:E6.
47. Poole SR. Criteria for measurement of dehydration. Ann Emerg Med 1990;19:730e731.
48. Vullo-Navich K, Smith S, Andrews M, et al. Comfort and incidence of abnormal serum sodium, BUN, creatinine and osmolality in dehydration of terminal illness. Am J Hosp Palliat Care 1998;15: 77e84.
49. Leibovitz A, Baumoehl Y, Lubart E, et al. Dehydration among long-term care elderly patients with oropharyngeal dysphagia. Gerontology 2007;53: 179e183.
50. Berk L, Rana S. Hypovolemia and dehydration in the oncology patient. J Support Oncol 2006;4: 447e454.
51. Fried LF, Palevsky PM. Hyponatremia and hypernatremia. Med Clin North Am 1997;81:585e609.
52. Alsirafy SA, Sroor MY, Al-Shahri MZ. Predictive impact of electrolyte abnormalities on the admission outcome and survival of palliative care cancer referrals. J Palliat Med 2009;12:177e180.
53. Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S. Determinants of the sensation of thirst in terminally ill cancer patients. Support Care Cancer 2001;9: 177e186.
54. Ellershaw JE, Sutcliffe JM, Saunders CM. Dehydration and the dying patient. J Pain Symptom Manage 1995;10:192e197.
55. Guo Y, Hainley S, Palmer JL, Bruera E. Azotemia in cancer patients during inpatient rehabilitation. Am J Hosp Palliat Care 2007;24:264e269.
56. Waller A, Hershkowitz M, Adunsky A. The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients. Am J Hosp Palliat Care 1994;11:22e27.
57. Burge FI. Dehydration symptoms of palliative care cancer patients. J Pain Symptom Manage 1993;8:454e464.
58. Galanakis C, Mayo NE, Gagnon B. Assessing the role of hydration in delirium at the end of life. Curr Opin Support Palliat Care 2011;5:169e173.
59. Keeley PW. Delirium at the end of life. Clin Evid (Online) 2009. Available from: http://www.ncbi. nlm.nih.gov/pmc/articles/PMC2907814/pdf/2009- 2405.pdf. Accessed August 2, 2012.
60. Galanakis C, Mayo N, Gagnon B. The role of hydration at the end of life. J Palliat Care 2010;26:249. (P421).
61. Yamaguchi T, Morita T, Shinjo T, et al. Effect of parenteral hydration therapy based on the Japanese national clinical guideline on quality of life, discomfort, and symptom intensity in patients with advanced cancer. J Pain Symptom Manage 2012;43: 1001e1012.
62. Musgrave CF, Bartal N, Opstad J. The sensation of thirst in dying patients receiving i.v. hydration. J Palliat Care 1995;11:17e21.
63. Nakajima N. A clinical study on the influence of hydration volume toward symptoms in terminally ill cancer patients with abdominal malignancies. Palliat Med 2012;26:462. (P23).
64. Sarhill N, Walsh D, Nelson K, Homsi J, Komurcu S. Bioelectrical impedance, cancer nutritional assessment, and ascites. Support Care Cancer 2000;8:341e343.
65. Piccoli A. Patterns of bioelectrical impedance vector analysis: learning from electrocardiography and forgetting electric circuit models. Nutrition 2002;18:520e521.
66. Piccoli A. Whole bodydsingle frequency bioimpedance. Contrib Nephrol 2005;149:150e161.
67. Piccoli A, Pillon L, Dumler F. Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. Nutrition 2002;18:153e167.
68. Barbosa-Silva MC, Barros AJ, Wang J, Heymsfield SB, Pierson RN Jr. Bioelectrical impedance analysis: Population reference values for phase angle by age and sex. Am J Clin Nutr 2005;82: 49e52.
69. Schwenk A, Beisenherz A, Romer K, et al. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr 2000;72:496e501.
70. Ott M, Fischer H, Polat H, et al. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:20e25.
71. Fein PA, Gundumalla G, Jorden A, et al. Usefulness of bioelectrical impedance analysis in monitoring nutrition status and survival of peritoneal dialysis patients. Adv Perit Dial 2002;18:195e199.
72. Mushnick R, Fein PA, Mittman N, et al. Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients. Kidney Int Suppl 2003;87:S53eS56.
73. Chertow GM, Lazarus JM, Lew NL, Ma L, Lowrie EG. Bioimpedance norms for the hemodialysis population. Kidney Int 1997;52:1617e1621.
74. Gupta D, Lammersfeld CA, Vashi PG, et al. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008;8:249.
75. Gupta D, Lammersfeld CA, Vashi PG, et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV nonsmall cell lung cancer. BMC Cancer 2009;9:37.
76. Gupta D, Lammersfeld CA, Burrows JL, et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 2004;80:1634e1638.
77. Gupta D, Lis CG, Dahlk SL, et al. Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr 2004;92: 957e962.
78. Crawford GB, Robinson JA, Hunt RW, Piller NB, Esterman A. Estimating survival in patients with cancer receiving palliative care: is analysis of body composition using bioimpedance helpful? J Palliat Med 2009;12:1009e1014.
79. McDonald JJ, Chanduvi B, Velarde G, et al. Bioimpedance monitoring of rehydration in cholera. Lancet 1993;341:1049e1051.
80. Bozzetto S, Piccoli A, Montini G. Bioelectrical impedance vector analysis to evaluate relative hydration status. Pediatr Nephrol 2010;25:329e334.
81. Codognotto M, Piazza M, Frigatti P, Piccoli A. Influence of localized edema on whole-body and segmental bioelectrical impedance. Nutrition 2008;24:569e574.
82. Nescolarde L, Piccoli A, Roman A, et al. Bioelectrical impedance vector analysis in haemodialysis patients: Relation between oedema and mortality. Physiol Meas 2004;25:1271e1280.
83. Piccoli A. Bioelectric impedance vector distribution in peritoneal dialysis patients with different hydration status. Kidney Int 2004;65:1050e1063.
84. Pillon L, Piccoli A, Lowrie EG, Lazarus JM, Chertow GM. Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis. Kidney Int 2004;66:1266e1271.
85. Toso S, Piccoli A, Gusella M, et al. Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated disease. Nutrition 2003;19:510e514.
86. Toso S, Piccoli A, Gusella M, et al. Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition 2000;16:120e124.
87. Malecka-Massalska T, Smolen A, Zubrzycki J, Lupa-Zatwarnicka K, Morshed K. Bioimpedance vector pattern in head and neck squamous cell carcinoma. J Physiol Pharmacol 2012;63:101e104.
88. Price KA. Hydration in cancer patients. Curr Opin Support Palliat Care 2010;4:276e280.
89. Waitt C, Waitt P, Pirmohamed M. Intravenous therapy. Postgrad Med J 2004;80:1e6.
90. Ross C, Cornbleet M. Attitudes of patients and staff to research in a specialist palliative care unit. Palliat Med 2003;17:491e497.
91. Glore RJ, Spiteri-Staines K, Paleri V. A patient with dry mouth. Clin Otolaryngol 2009;34:358e363.
92. McCann RM, Hall WJ, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 1994;272: 1263e1266.